Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
With-HF: Spironolactone Withdrawal in HFimpEF
NCT04367051Completed
- Sponsor
- Asan Medical Center
- Start
- Aug 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of spironolactone in heart failure (HF) (2 arms), sponsored by Asan Medical Center. Primary endpoint: Change of left ventricular ejection fraction at 6 months. Started Aug 2020; status: completed.
02
Drugs
spironolactone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04367051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04367051.